HDA’s 2026 Healthcare Outlook Highlights the Industry’s Policy Priorities
Chain Drug Review, a pharmacy trade publication, published its annual “Healthcare Outlook” column by HDA President and CEO Chip Davis, which examines the industry’s priorities for 2026. Delving into the ongoing economic and policy pressures shaping the distribution industry, the piece highlights the critical role of pharmaceutical distributors in ensuring patient access amid an evolving healthcare landscape. It also underscores the industry’s commitment to ongoing collaboration with partners across the supply chain to support community care.
“Distributors and policymakers share a common goal: strengthening healthcare for the patients who depend on it," Davis writes in the piece. "As we enter 2026, our industry stands ready to support a stronger, more accessible and affordable healthcare system for all.”
Read the full column here.